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Abstract
Background—The Glutathione-S-Transferase Mu 1 null genotype has been reported to be a risk
factor for acute respiratory disease associated with increases in ambient air ozone. Ozone is known
to cause an immediate decrease in lung function and increased airway inflammation. However, it
is not known if GSTM1 modulates these ozone responses in vivo in humans
Objective—The purpose of this study was to determine if the GSTM1 null genotype modulates
ozone responses in humans.
Methods—Thirty-five normal volunteers were genotyped for the GSTM1 null mutation and
underwent a standard ozone exposure protocol to determine if lung function and inflammatory
responses to ozone were different between the 19 GSTM1 normal and 16 GSTM1 null volunteers.
Results—GSTM1 did not modulate lung function responses to acute ozone. Granulocyte influx 4
hours after challenge was similar between GSTM1 normal and null volunteers. However, GSTM1
null volunteers had significantly increased airway neutrophils 24 hours after challenge, as well as
increased expression of HLA-DR on airway macrophages and dendritic cells.
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Conclusion—The GSTM1 null genotype is associated with increased airways inflammation 24
hours following ozone exposure, consistent with the lag time observed between increased ambient
air ozone exposure and exacerbations of lung disease.
Clinical Implications—These observations suggest that the GSTM1 null genotype likely
confers increased risk for exacerbation of ozone-induced lung disease through promoting an
enhanced neutrophilic and monocytic inflammatory response to ozone.
Capsule summary—The GSTM1 null genotype is associated with increased risk for ozone-
induced lung disease. We report the GSTM1 genotype modulates ozone-induced inflammation but
not lung function, and may predict persons at risk for environmental lung disease.
Keywords
Glutathione-S-Transferase Mu 1; Ozone; Pollution; Inflammation; Polymorphonuclear Neutrophil;
Macrophage; Dendritic cell
Introduction
A number of pro-oxidant air pollutants, including particulate matter, tobacco smoke, diesel
exhaust and ozone (O3) have been linked to exacerbation of asthma and lung disease(1–5).
Glutathione-S-Transferase Mu 1 (GSTM1) is a Phase II antioxidant enzyme regulated by the
transcription factor NF-E2-related factor-2 (NRF2)(6). The GSTM1 null (GSTM1−)
genotype results in a failure to produce the GSTM1 protein. As noted in many reviews, the
GSTM1− genotype confers increased risk for adverse health effects due to exposure to these
air pollutants(1–5). As reviewed by Giesler and Olshan(7), case-control studies conducted in
the United States of various tumors report frequencies of the GSTM1− genotype that range
from 23 to 41 percent in African Americans, 32 to 53 percent in Asian Americans, 40 to 53
percent in Hispanic Americans, and 35 to 62 percent in European Americans. Furthermore,
prevalence of the GSTM1− genotype ranges from 48 to 57 percent in European Americans
as reported in several population studies. Thus, this gene variant occurs in high frequency in
most ethnic populations.
Many investigators have reported increased susceptibility to lung disease following
exposure to environmental tobacco smoke associated with the GSTM1− genotype. One
study of children exposed to environmental tobacco smoke found that those children who
were either GSTM1− or homozygous for the GSTP1Val105 allele had increased risk of
asthma at younger ages, with an increased risk for decreased lung function in adolescence.
(8) Others have reported that children with the GSTM1− genotype are significantly more
likely to have increased risk of asthma or acute respiratory illnesses if they are born to
mothers who smoke during pregnancy (9) or if they had been exposed to environmental
tobacco smoke(10). Human challenge studies have been conducted to investigate the role of
the GSTM1− genotype on the interaction of second-hand tobacco smoke exposure with
diesel exhaust exposure on response to allergen in allergic volunteers. In these studies,
GSTM1− volunteers have increased allergen-induced histamine release and IgE production
in the nasal airway following exposure to these pollutants(11;12).
A series of reports of a cohort of children with asthma in Mexico City have demonstrated an
effect of ambient air O3 exposure on asthma exacerbation. This group reported that
asthmatic children with the GSTM1− genotype have increased risk for O3-induced asthma
exacerbation, and are more likely to benefit from antioxidant supplementation to prevent
such exacerbations. They have also reported that the Pro/Pro homozygous genotype (vs. Pro/
Ser or Ser/Ser genotypes) at the 187 position for the NAD(P)H:quinone oxidoreductase
(NQO1), increases risk for asthma in GSTM1−children(13–16). Another study examined the
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effect of O3 levels of > 0.08 ppm on 24 bicyclists while undertaking a 2 hour ride on lung
function and serum levels of CC16 (Clara Cell Protein 16) which is a marker for increased
respiratory cell permeability (17). Eight of these 24 persons had both the wild type NQO1
genotype and the GSTM1−genotype and were found to have a strong correlation between
both serum CC16 and decreased lung function and ambient air O3 levels >0.08 ppm. Taken
together, these observations indicate that the GSTM1−genotype is an important determinant
of susceptibility to O3-induced lung disease.
Human challenge studies of both asthmatic and non-asthmatic adults revealed three distinct
responses following O3 challenge: an immediate decrease in lung function which is most
likely mediated by neural reflexes; increased bronchial reactivity; and increases in airway
inflammation typified by increased influx of polymorphonuclear neutrophils (PMNs) (18).
The effect of O3 challenge on macrophage and monocyte populations is still being defined.
Acute O3 challenge has been reported to decrease macrophage numbers in the airway
(18;19), while others have found that repeated exposure to O3 augments airway macrophage
populations(20). Additionally, we have reported that exposure to O3 causes increased
expression of a number of innate and acquired immune surface proteins on airway
monocytes and macrophages, including CD11b, CD14, CD16, CD86 and HLA-DR, that
occur in concert with increases in airway PMNs(19). We hypothesized that an important
mechanism by which O3 exerts adverse respiratory effects in humans involves recruitment
of activated innate immune cells to the airway with enhanced expression of cell surface
proteins like CD14, CD86 and HLA-DR. These cells would likely enhance response to
allergen in allergic persons as well as responses to particulates containing biological
components such as endotoxin which may have health effects in allergic and non-allergic
populations.
To test this hypothesis, healthy volunteers who had the GSTM1+ or GSTM1− genotype
underwent inhalation challenge to 0.4 ppm O3 for two hours. Changes in lung function,
PMN and macrophage numbers, expression of cell surface markers on immune cells,
macrophage function and cytokine levels were examined. If the GSTM1− genotype is
associated with decreased lung function or increased airway neutrophil and macrophage
responses to O3, then this would be an important risk factor for acute disease morbidity
associated with O3.
METHODS
Volunteer Recruitment and Inclusion Criteria
This protocol was reviewed and approved by the University of North Carolina Committee
on the Rights of Human Subjects (Institutional Review Board). All subjects underwent a
physical examination, a routine blood panel with CBC and differential, allergy skin testing,
and genotyping for the GSTM1− or GSTM1+ genotype using previously reported
techniques(21). Subjects were required to have a negative methacholine challenge. Female
subjects had to have a negative urine pregnancy test prior to challenge and all volunteers
were required to be free of chronic cardiovascular or respiratory illness, and be free of acute
respiratory illness within 4 weeks of O3 challenge. All subjects had FEV1 and FVC ≥ 80%
predicted and FEV1/FVC ≥ 75% predicted normal for height and age, and were non-
smokers with no smoking history. All subjects were screened for their ability to provide an
adequate induced-sputum sample during their training session. Further recruitment criteria
are detailed in the online supplement,
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Ozone Exposure and testing protocol
Ozone Exposures—The O3 exposures were conducted in an O3 exposure chamber at the
US-EPA Human Studies Facility on the campus of the University of North Carolina, Chapel
Hill, NC. Each subject was exposed to O3 (0.4 ppm) for 2 hours while performing four 15
minute sessions of intermittent moderate exercise (minute ventilation or VEmin = 30–40 L/
min) on a treadmill, separated by 15 minutes of seated rest. Lung function, breath sounds,
and vital signs were assessed before and after exposure.
Sputum was obtained 4 and 24 hour post exposure and processed as previously described.
(22;23) This is further outlined in the online supplement. Sputum was assessed for total and
differential cell counts, immunophenotyping of neutrophils, macrophages, monocytes, and
dendritic cells,(19;24) and functional assays for oxidative burst activity and phagocytosis of
opsonized zymosan were assessed by flow cytometry on sputum macrophages(22;25).
Sputum supernatants were also assessed for cytokine concentration, as described in the
online supplement. Lung function and genotyping procedures are also described in the
online supplement.
Statistical Analysis
Our a priori primary hypotheses were that persons with the GSTM1− genotype would have
increased effects of O3 on lung function (greater decrements in lung function) and airway
inflammation (increases in airway neutrophils and decreases in airway macrophages). The
effect of O3 on airway cell immunophenotypes and macrophage function were also
determined to test the exploratory hypotheses that persons with the GSTM1− genotype
would have enhanced airway macrophage activation and cell function.
Paired t-tests were used to compare each effects of O3 lung function immediately and 24
hours after challenge and sputum endpoints at 4 and 24 hours post challenge to baseline
measures within each genotype cohort (GSTM1− and GSTM1+) to first determine the effect
of O3 on these endpoints. To test the primary hypothesis that persons with the GSTM1−
genotype have enhanced responses to O3, we compared the change from baseline at 4 or 24
hours for a given endpoint after O3 challenge between the GSTM1− and GSTM1+ groups
using the two sample t-test. Spirometric data immediately and 24 hours after challenge were
normalized and expressed as % change from baseline. Other endpoints were transformed
using natural logarithm transformation to achieve a normal distribution prior to T-test
analysis. For primary hypotheses, significance was set at α=0.05. For exploratory
hypotheses, nominal p values <0.10 are reported.
Although the ability to produce adequate sputum was an entrance criterion, some sputum
samples recovered at baseline or after challenge did not yield a sufficient numbers of cells
for recovery of all endpoints. This occurred randomly across the baseline, 4-hour post and
24-hours post exposure sputum collections. To account for the missing data points and
maximize statistical power for hypothesis testing, we employed multiple imputation
methods (26). Data imputation was not performed on any endpoint where a subject had
missing data at all timepoints due to inadequate sputum cell recovery. For all primary
endpoints, the sample size is n=19 for GSTM1+ and n=16 for GSTM1− volunteers. For
exploratory endpoints, the assessed sample size is noted in the results section. Thirty
imputations were performed for each set of sputum endpoints (e.g. baseline PMN/mg
sputum values in GSTM1+ volunteers) which contained missing data. Only mean and
standard error values from actual data are depicted and reported in the results section, with
imputed data used only for hypothesis testing. A detailed description of the imputation
methodology appears in the on line supplement.
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Demographic data for the thirty-five healthy volunteers, ranging in age from 18–35 years,
recruited for challenge to 0.4 ppm O3 are presented in Table 1. Twelve of the 35 (32.3%)
were atopic as determined by skin testing, though all were non-asthmatic as determined by
methacholine challenge. The GSTM1 genotype cohorts are described in Table 1.
Effect of 0.4 ppm ozone on lung function
The effect of O3 on lung function was a primary endpoint for this study. Figure 1 shows that
O3 exposure caused significantly (p<0.05) decreased FEV1 (top) and FVC (bottom)
immediately after challenge in GSTM1+ (N=19) and GSTM1− (N=16) subjects and are
expressed as % of baseline value. No significant differences in lung function responses to O3
were found between the GSTM1+ and GSTM1− cohorts, with both cohorts having
significant and similar decreases in FEV1 and FVC at immediately and 24 hours post
exposure.
Effect of 0.4 ppm ozone on airway PMNs and macrophages
The effect of O3 on airway PMNs and macrophages was also a primary endpoint for this
study. Figure 2 (top) shows that the GSTM1− cohort (n=16) had significantly increased
sputum PMNs 4 (*p=0.021), and 24 hours (*p=0.001) after challenge. The GSTM1+ cohort
had significantly increased sputum PMNs 4 hours after challenge (*p=0.01) with a relative
decrease in PMNs at 24 hours such that they were not significantly increased compared to
baseline. A comparison of the changes from baseline to 24 hours after challenge in the
GSTM1+ and GSTM1− cohorts demonstrated that the GSTM1− cohort had a significantly
increased PMN influx 24 hours after challenge (+p=0.03).
The bottom panel in Figure 2 shows that macrophage counts were significantly decreased
from baseline values 4 (*p=0.013) and 24 hours (*p=0.001) after O3 exposure in the
GSTM1+ group. In the GSTM1− group, a small, non-significant decrease in macrophage
numbers was found at 4 hours after challenge compared to baseline, with the mean value
increasing to a level above that seen at baseline at 24 hours. A comparison of the 24 hour
macrophage response in the GSTM1+ and GSTM1− cohorts demonstrated that the GSTM1−
cohort had a significantly increased macrophage count 24 hours after challenge (+p=0.002).
For macrophages and neutrophils, data was recovered 17 of 19 GSTM1+ volunteers at
baseline, all volunteers 4 hours post challenge, and 17 of 19 24 hours after challenge. For
GSTM1− volunteers, data was recovered from 15 of 16 volunteers at baseline and 4 hours,
and 13 of 16 volunteers 24 hours post challenge. Multiple imputation techniques were used
to estimate missing values for each data set as described in the Methods section.
Effect of 0.4 ppm ozone on airway macrophage and dendritic cell function
Two measures of macrophage function, were assessed as exploratory endpoints: oxidative
burst activity following activation with zymosan particles (Figure 3, top panel) and uptake
of opsonized zymosan particles, phagocytosis (Figure 3, middle panel). Oxidative burst was
increased in airway macrophages recovered from GSTM1− volunteers (n=16) 24 hours after
O3 challenge when compared to macrophages from 17 GSTM1+ volunteers (+p=0.03).
Macrophage phagocytosis was increased 24 hours after O3 challenge in GSTM1− (n=15) vs.
GSTM1+ (n=19) volunteers (+p=0.05).
Another exploratory endpoint we examined was the effect of O3 on cell surface phenotypes
on monocyte and macrophage populations as defined using flow cytomtery. We focused on
the effect of O3 on expression of CD11b, CD14, CD16, CD64, CD86 and HLA-DR in
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monocytes, immature macrophages, mature macrophages, PMNs and dendritic cells. We
have previously reported that O3 exposure enhances expression of these markers on airway
monocytes after O3 challenge, and confirmed this observation in the present study with the
exception of CD16 (data not shown). When we analyzed the effect of O3 on surface marker
expression in the GSTM1+ (N=9) and GSTM1− (N=11) groups (Figure 3, bottom panel), we
found three significant differences at 24 hours for GSTM1− individuals: 1) increased
expression of CD14 on airway PMNs (Figure E1, online supplement); 2) increased
expression of HLA-DR on airway dendritic cells at 24 hours post exposure (*p=0.003) and
3) increased HLA-DR expression on macrophages (*p=0.03) 24 hours post exposure. The
24 hour HLA-DR response was significantly different between GSTM1+ and GSTM1−
volunteers for dendritic cells (+p=0.02) and macrophages (+p=0.03).
Airway Cytokines
We also examined sputum supernatants for a number of pro-inflammatory cytokines
(gamma interferon, IL-1β, IL-2, IL-4, IL-5, IL-8, IL-10, IL-12p70, IL-13, MIP1α and
TNFα). Of these, we observed significant increases in IL-1β at 4 (p=0.01) and 24 hours
(p=0.05) post O3 and IL-8 24 hours post O3 in the GSTM1− cohort, while the GSTM1+ also
showed elevated levels but these were not statistically significant. No difference between
genotypes was observed. These results are further described in the online supplement
DISCUSSION
In this study, we tested the hypothesis that the GSTM1− genotype would increase sensitivity
to inhaled challenge to 0.4 ppm O3, with the primary endpoints being change in lung
function (FEV1 and FVC) and influx of neutrophils to the airway four and 24 hours after
acute challenge. We found decreased mean FEV1 and FVC after O3 challenge in GSTM1+
and GSTM1− volunteers had with no difference in lung function response between these
groups. We likewise found no difference in airway neutrophils 4 hours after challenge
between the genotype groups, with both groups demonstrating increased airway neutrophils.
However, at 24 hours post O3 challenge, we found a very notable and significant increase in
airway neutrophils in the GSTM1− cohort that was not found in the GSTM1+ group.
We also found that there was a significant decrease in the macrophages/mg sputum
recovered in the GSTM1+ volunteers at 4 and 24 hours that was not observed in the
GSTM1− group. Macrophage-mediated clearance of apoptotic luminal cells would depend
on the presence of apoptotic PMNs in the airways, hence PMN resolution resulting in fewer
PMNs at 24h in the GSTM1+ cohort may explain fewer macrophages at that time point.
Persistent inflammation however, as observed in the GSTM1− cohort at 24 hours may render
the need for increased macrophages and enhanced macrophage-mediated clearance. Thus,
comparing the differences in the change from baseline values between the groups at 24
hours after challenge, the GSTM1− volunteers had a significantly greater number of
macrophages present in the airway. When compared to baseline values, oxidative burst and
phagocytic capability of airway macrophages recovered 24 hours after O3 challenge were
increased in the GSTM1− vs the GSTM1+ volunteers. We also observed increased HLA-DR
expression on macrophages and dendritic cells recovered from GSTM1− volunteers 24 hours
after challenge. We have previously reported that concurrent with O3-induced cell changes
in the airway, namely neutrophil and monocytic cell influx, there are increases in expression
of innate and acquired immune cell surface proteins on airway macrophages and monocytes.
These include CD11b, CD14, CD86 and HLA-DR (19). The persistence of macrophages in
the airways of GSTM1− volunteers 24 hours after challenge is therefore likely biologically
significant because these cell surface proteins are central in mediating innate and acquired
immune responses that can mediate exacerbations of lung disease.
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Adverse events associated with increases in ambient air O3 exposure generally occur 24 to
48 hours after the O3 event has occurred as reviewed by Peden et al (18). As described in the
Introduction, the GSTM1− genotype is associated with increased risk for such adverse
events. If these effects were primarily due to an immediate effect of O3 on lung function, air
pollution events should result in immediate (same day) exacerbation of disease. Our
observations that GSTM1− volunteers have increased neutrophilic inflammation in the
airway, increased presence of functionally activated macrophages, and increased expression
of HLA-DR on airway macrophages and dendritic cells 24 hours after O3 challenge suggest
that these inflammatory and innate immune changes likely account for these effects. These
changes could directly modify the airway, or perhaps in the case of allergic asthmatics,
enhance response to inhaled allergen, which has been reported by many investigators, as
noted previously(18).
It is unclear whether the increases in neutrophils and macrophages in the airways 24 hours
after O3 challenge in GSTM1− volunteers reflects a primary difference in these cells, or
increased chemo-attraction and activation of inflammatory and immune cells by mediators
secreted by structural tissues of the airway following exposure to O3. There is ample
evidence that O3 stimulates airway epithelial cells in ways which may influence
inflammation. Ozone up-regulates cytokine and eicosanoid secretion by epithelial cells, as
noted previously(27;28) and reported here in the GSTM1− cohort, as they demonstrated
significantly elevated levels of the pro-inflammatory cytokines IL1-β and IL-8 following O3,
the latter a potent chemoattractant for PMN influx. Epithelial cells stressed with O3 also
release ATP, which is a pro-inflammatory signal for a number of inflammatory cells(29).
Ozone actions on epithelial lining fluid may also result in production of lipid peroxidation
products that have pro-inflammatory actions (27;28;30;31).
There are suggestions that the airway epithelium of GSTM1− individuals has increased
susceptibility to O3. A study of the effect of in vitro O3 exposure on nasal mucosal explants
obtained from GSTM1+ and GSTM1− volunteers reveals that tissues from GSTM1−
volunteers have significantly increased superoxide dismutase activity relative to GSTM1+
tissues(32). In the study by Bergamaschi et al examining the effect of ambient O3 on
bicyclists, the GSTM1− genotype was a component of the haplotype associated with a
correlation between O3 and Clara Cell Protein 16 (CC16), a marker of epithelial cell
injury(17). Taken together, these observations suggest that airway epithelial cells from
GSTM1− persons have increased susceptibility to O3. We hypothesize that GSTM1
genotype-mediated differences in epithelial cell secretion of pro-inflammatory cytokine
response to O3 may account at least in part, for the effect of the GSTM1− genotype on O3-
induced airway inflammation.
It is important to note limitations to the current study. We did not assess changes in airway
hyperresponsiveness, and we acknowledge that such changes could also account for
increased risk for exacerbation of O3-induced disease associated with the GSTM1−
genotype. Also, in contrast to our study, Bergamaschi et al found that bicyclists exposed to
lower levels of ambient O3 (0.08 ppm) had a significant effect on lung function in those with
the NQO1 wild type/GSTM1− haplotype (17). It is possible that the level of O3 we
employed in this study may have been so high that a GSTM1 genotype modulation of lung
function response may have been masked.
Additionally, 16 of 16 of our GSTM1− volunteers were Caucasian, whereas 8 of the 19
GSTM1+ volunteers were African American,1 was Asian and 10 were Caucasian. The
sample size of this study limits the ability to adjust for ethnicity, and it is possible that the
differences we observed between the GSTM1+ and GSTM1− populations in this study may
be due to other genetic factors which stratify by race, rather than GSTM genotype. If factors
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other than differences in the GSTM genotype accounted for the differential responses to
ozone we observed, then mechanisms other than impaired antioxidant capability would need
to be explored as potential risk factors for pollutant-induced lung inflammation. However, as
noted in the Introduction, the prevalence of the GSTM1− genotype is high across most
studied ethnic groups. As future studies enhance our sample size, we will need to confirm
that the effect of the GSTM1− genotype on O3 induced inflammation is true across multiple
ethnic groups, which would make it less likely that other factors account for the differences
we report herein.
In summary, we report that volunteers with the GSTM1− genotype have no differential lung
function response to 0.4 ppm O3 compared to the GSTM1+ group, but do have a notable
increase in airway PMNs and activated macrophages at 24 hours post O3 challenge
compared to GSTM1+ volunteers. The GSTM1− genotype has been associated with
increased risk for exacerbations of airway disease and asthma due to pollutant exposure. Our
observations on inflammatory response to O3 in GSTM1− volunteers temporally matches the
epidemiological observations that show ambient O3-associated adverse effects 24 hours after
exposure. Taken together, these observations are consistent with the hypotheses that GSTM1
is an important risk factor for O3-induced exacerbations of respiratory disease due in part to
GSTM1−associated differences in inflammatory response to O3.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Abbreviations
GSTM1 Glutathione-S-Transferase Mu 1
O3 Ozone
NQO1 NAD(P)H:quinone oxidoreductase
NRF2 Nuclear Factor-E2-related factor-2
PMN Polymorphonuclear Neutrophil
FVC Forced Vital Capacity
FEV1 Forced expiratory Volume at one second
CC16 Clara Cell Protein 16
DC Dendritic Cell
MFI mean fluorescence intensity
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VEmin Expiratory minute ventilation
DTT dithiothreitol
DC dendritic cell
MFI Mean Fluorescence Intensity
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Figure 1. Effect of GSTM1 genotypes on lung function response to O3
FEV1 (top panel) and FVC (bottom panel) expressed as mean (SEM) percent of baseline
value 4 and 24 hours after O3 exposure in GSTM1+ (N=19, closed bars) and GSTM1−
(N=16, open bars ).
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Figure 2. Effect of GSTM1 genotypes on PMN and macrophage numbers in sputum in response
to O3
Mean (SEM) PMNs/mg sputum (top panel) and macrophages/mg sputum (bottom panel) pre
(baseline), 4 and 24 hours post O3 exposure in GSTM1+ (N=19 closed bars) and GSTM1−
(N=16 open bars) individuals. * p<0.05 vs. baseline; +p<0.05 GSTM1+ vs GSTM1−
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Figure 3. Effect of GSTM1 genotypes on cell function 24 hours after O3 exposure
Mean (SEM) oxidative burst activity, MFI (top, macrophages, GSTM1+ =17, GSTM1−
=16), phagocytosis (middle, macrophages, GSTM1+ =19, GSTM1− = 15) and HLA-DR
expression, MFI (bottom, GSTM1+ = 9. GSTM1− = 11) at 4 and 24 hours following ozone
exposure in GSTM1+ and GSTM1− individuals. * p<0.05 vs pre; + p<0.05 for 24 hour
response in GSTM1+ vs GSTM1− individuals
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